Women’s health is having a moment. More investment, more founders, more attention than this field has ever seen. That excites me. It also makes me nervous, because moments pass, and the question is whether this one actually changes anything for women.
What excites me most is that women’s health is finally moving beyond fertility and menopause. Not because those areas matter less, but because we are starting to recognise how much has been missed everywhere else. Cardiovascular disease is the leading cause of death in women worldwide, yet almost everything we know about risk, symptoms and treatment was built around male populations. That is a profound gap, and one that technology can help close.
What many people don’t realise is that pregnancy offers one of the earliest windows to detect a woman’s lifetime cardiovascular risk. Hypertensive disorders of pregnancy, conditions like pre-eclampsia, are among the strongest predictors of future heart disease. Yet in most healthcare systems, that window closes the moment a woman leaves the maternity ward. We treat the complication and send her home, missing the opportunity to intervene before chronic disease takes hold. AI changes that. For the first time, we have tools that can monitor risk continuously, detect patterns early, and follow women beyond the clinic, turning a brief window into a lifelong opportunity for prevention.
AI doesn’t just make existing care faster or cheaper. It makes entirely new things possible – continuous remote monitoring, early risk detection outside of clinical settings, and personalised support that follows a woman through pregnancy and beyond. That is not an incremental improvement; it is a different model of care.
What our pilots have taught us is that technology is rarely the hardest part. The harder questions are about trust and implementation. Whether women will engage, whether clinicians will act on what the data shows, whether health systems are ready to intervene earlier. For AI to be genuinely adopted in clinical settings, trust needs to be earned through scientific rigour, tangible outcomes, robust regulatory frameworks and deep clinical evidence. Building that requires clinicians, researchers, founders, regulators and investors working through these challenges together.Â
That is why we organised the AI × Women’s Health: Innovation, Challenges and Opportunities summit. The response surprised even us. All 140 places sold out, with a waiting list. That tells me something important. There is a community here, ready and hungry for this conversation.
Women’s health is finally receiving the attention it deserves. The task now is to make sure this moment doesn’t pass without delivering real change for women. That is a conversation worth bringing people together for.
AI × Women’s Health: Innovation, Challenges and Opportunities is taking place on Thursday 25 June 2026 at the London Institute for Healthcare Engineering. The event is free and fully booked with a waiting list. To join the waiting list here –Â
Â
